Skip to main content
. 2021 Nov 13;46(3):473–480. doi: 10.1016/j.jgr.2021.11.005

Fig. 3.

Fig. 3

The effects of KGC11o on dihydrotestosterone (DHT), 5ARI and prostate specific antigen (PSA) level. (A, B) DHT level in serum and prostate tissue showing a significant decrease with KGC11o. (C–E) Effects of KGC11o on the level of 5AR2 in the serum and prostate and that of 5AR1 in the serum. (F) Prostate specific antigen (PSA) level reduced by KGC11o dose-dependently in serum. Alphabet a, b, c and d indicate significant differences at p < 0.05 by Duncan's multiple range test (DMRT).